Back to results
US 11,447,449 B2Granted
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
AssigneeBristol-Myers Squibb Company
InventorsJames Aaron Balog, Steven P. Seitz, David K. Williams, Murugaiah Andappan Murugaiah Subbaiah
Life of this patent
Estimating the term…
Abstract
The present invention provides a compound of formula (II): an inhibitor of indoleamine 2,3-dioxygenase (IDO), which may be used as medicaments for the treatment of proliferative disorders, such as cancer, viral infections and/or autoimmune diseases. Its prodrugs are disclosed.
Claims9
A compound of formula (I):
- wherein:
- R1 is a straight or branched C1-C8 alkyl substituted with
- R2,
- Y is CH or N;
- L1 is independently a bond or a straight or branched C1-C8 alkylene;
- L2 is independently a bond, a straight or branched C1-C8 alkylene,
- —OC(O)N(Rc)CH(Rb)—, —C(O)N(Rc)L3-, C3-C6 cycloalkyl,
- R2 is independently NH2,
- L3 is independently a straight or branched C1-C6 alkylene;
- L4 is independently a bond, a straight or branched C1-C6 alkylene wherein two carbon atoms of said alkylene are optionally replaced by —C(O)N(Rc)— or —N(Rc)C(O)—;
- R3, R4, R5 and R6 are independently H or C1-C4 alkyl;
- R7 and R8 are independently H or C1-C6 alkyl;
- R9 is aryl optionally substituted with one to three substituents selected from:
- halo, OH, CN, C1-C6 alkyl, —OC1-C6 alkyl, C1-C6 haloalkyl, benzyl, and phenoxy;
- Ra is independently halo, OH, CN, C1-C6 alkyl, —OC1-C6 alkyl, or C1-C6 haloalkyl;
- Rb and Rc are independently H, or C1-C6 alkyl;
- Rd is independently H, C1-C6 alkyl, —CH2OC(O)(C1-C6 alkyl), —CH2OC(O)O(C1-C6 alkyl), or Bn;
- and
- Re is independently C1-C6 alkyl optionally substituted with a substituent selected from halo, OH, CN, C1-C4 alkyl, —OC1-C6 alkyl, and C1-C4 haloalkyl;
- or a salt, a stereoisomer, a tautomer, or a solvate thereof.
17 more elements
Dependencies are inferred from the claim text.